Daiwa Securities Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Hold |
593
| – | – | ﹤0.01% | 1150 |
|
|
2025
Q1 | $4K | Hold |
593
| – | – | ﹤0.01% | 1152 |
|
|
2024
Q4 | $5K | Hold |
593
| – | – | ﹤0.01% | 1165 |
|
|
2024
Q3 | $5K | Buy |
593
+186
| +46% | +$1.57K | ﹤0.01% | 1169 |
|
|
2024
Q2 | $3K | Hold |
407
| – | – | ﹤0.01% | 1224 |
|
|
2024
Q1 | $4K | Buy |
407
+145
| +55% | +$1.43K | ﹤0.01% | 1216 |
|
|
2023
Q4 | $1K | Hold |
262
| – | – | ﹤0.01% | 1295 |
|
|
2023
Q3 | $1K | Hold |
262
| – | – | ﹤0.01% | 1260 |
|
|
2023
Q2 | $1K | Hold |
262
| – | – | ﹤0.01% | 1279 |
|
|
2023
Q1 | $1K | Hold |
262
| – | – | ﹤0.01% | 1260 |
|
|
2022
Q4 | $1K | Hold |
262
| – | – | ﹤0.01% | 1275 |
|
|
2022
Q3 | $1K | Hold |
262
| – | – | ﹤0.01% | 1294 |
|
|
2022
Q2 | $1K | Hold |
262
| – | – | ﹤0.01% | 1293 |
|
|
2022
Q1 | $1K | Hold |
262
| – | – | ﹤0.01% | 1311 |
|
|
2021
Q4 | $2K | Hold |
262
| – | – | ﹤0.01% | 1284 |
|
|
2021
Q3 | $3K | Buy |
262
+128
| +96% | +$1.47K | ﹤0.01% | 1213 |
|
|
2021
Q2 | $2K | Hold |
134
| – | – | ﹤0.01% | 1142 |
|
|
2021
Q1 | $2K | Hold |
134
| – | – | ﹤0.01% | 1148 |
|
|
2020
Q4 | $3K | Buy |
+134
| New | +$3K | ﹤0.01% | 1090 |
|
|
2019
Q4 | – | Sell |
-268
| Closed | -$1K | – | 1220 |
|
|
2019
Q3 | $1K | Hold |
268
| – | – | ﹤0.01% | 1143 |
|
|
2019
Q2 | $1K | Hold |
268
| – | – | ﹤0.01% | 1165 |
|
|
2019
Q1 | $1K | Buy |
+268
| New | +$1K | ﹤0.01% | 1151 |
|